1.Remote cerebral ischemic postconditioning for cerebral ischemia: pathophysiological mechanisms and clinical applications
Guomin YING ; Changhong REN ; Ying ZHANG
International Journal of Cerebrovascular Diseases 2014;22(3):204-208
Remote ischemic postconditioning can induce cerebral ischemic tolerance and have neuroprotective effects.It has provided a novel strategy for the treatment of ischemic cerebrovascular disease.In recent years,the mechanism research of remote ischemic postconditioning and clinical applications have made significant progress and have shown encouraging prospects of clinical transformation.
2.Effect of stellate ganglion block combined with morphine sustained-release tablets for controlling pain of advanced lung cancer
Xiaoqun ZHANG ; Ying FU ; Ailin DONG ; Binbin MA ; Guomin WANG
Chinese Journal of Primary Medicine and Pharmacy 2013;20(12):1774-1776
Objective To investigate the effect of stellate ganglion block combined with morphine sustainedrelease tablets for controlling pain of advanced lung cancer.Methods 90 cases with advanced lung cancer were randomly divided into the observation group and control group with 45 cases in each group.The control group was givenmorphine sustained-release tablets,the observation group received combination therapy with stellate ganglion block and morphine sustained-release tablets.The analgesic effects,quality of life scores and adverse reactions of two groups were compared.Results The effective rate of observation group was 93.33 % (42/45),which was significantly higher than that of control group 77.78% (35/45),the difference was statistically significant (x2 =4.54,P < 0.05).The morphine consumption of observation group was significantly less than that of control group(t =9.11,P < 0.05),duration of analgesia was significantly longer than that of control group (t =6.72,P < 0.05).Quality of life score in the observation group was significantly higher than that in the control group,the difference was statistically significant(Z =3.61,P < 0.05).The incidence rate of adverse reactions was 17.78% (8/45),which was significantly lower than that of the control group 46.67% (21/45),the difference was statistically significant (x2 =4.54,P < 0.05).Conclusion Stellate ganglion block combined with morphine sustained-release tablets for controlling pain of advanced lung cancer can significantly improve analgesia,reduce morphine consumption and adverse reactions,is worthy of clinical application.
3.Tracing transmembrane transport of amino-glucomannan
Yuan GUO ; Yongkang LIU ; Ying DU ; Hongtao LI ; Guomin CHEN
Journal of Third Military Medical University 2002;0(12):-
Objective To label the amino-glucomannan(AGM) with fluram and to explore the properties of the compound of fluram-AGM in transmembrane transport.Methods After AGM was labeled with fluram,the peripheral blood mononuclear cells(PBMC) and HepG2 were respectively cultured with Fluram-AGM,then observed under fluorescence microscope with violet light as exciting light.Results Both PBMC and HepG2 showed intracellular indigotic fluorescence.Conclusion AGM can be transported into cells across cell membrane.
4.Condensation mechanism of aminoglucomannan with plasmid DNA
Yuan GUO ; Yongkang LIU ; Hongtao LI ; Ying DU ; Guomin CHEN
Journal of Third Military Medical University 2003;0(14):-
Objective To study the condensation mechanism of aminoglucomannan(AGM)with plasmid DNA and some influencing factors in this process.Methods The polysaccharide-DNA complex was analyzed with agarose gel electrophoresis by observing the changes of DNA bands under various influencing conditions including different pH,ionic strength(NaCl concentration),temperature and plasmid DNA sorts.Results The new bands appeared in the slow migration positions after reaction between AGM and plasmid DNA,and the changes of DNA bands content were dependent on AGM concentrations.The condensation degree could be effected by pH,temperature,and ionic strength.Conclusion Our study suggests that the AGM can be condensed with plasmid DNA in proper conditions.
5.Study on the strategy of medical security for rare diseases in China from the perspective of public concern and emotion:taking nosinasine as an example
Yangfang TAI ; Ying GUO ; Ziqiong WANG ; Junhui WANG ; Guomin HUA ; Huili YANG ; Xiaojie WANG ; Peifeng HE
China Pharmacy 2023;34(7):774-779
OBJECTIVE To mine the focus and emotional attitude of the public on rare diseases, and to provide decision- making reference for relevant departments to formulate and implement relevant policies, systems and strategies for medical security of rare diseases. METHODS Latent Dirichlet allocation (LDA) topic model and sentiment analysis method were used to analyze the comment text of short videos related to the “nosinasine” medical insurance admission event on the Bilibili video website, mine the theme and sentiment tendency of the text, and put forward relevant strategy suggestions. RESULTS A total of 8 videos with tens of thousands of playback and 7 109 text data were obtained. According to the LDA analysis, online public paid attention to 9 topics related to rare diseases (the price of rare disease drugs, the inclusion of rare disease drugs in medical insurance, the status quo of research and development of rare disease drugs, the scope of medical insurance and the medical security system, the plight of rare disease patients, the prevention and screening of rare diseases, the value of rare disease drugs in medical insurance, the Chinese and western medical methods of rare diseases, and the supply and demand status of rare disease drugs), which could be summarized into 4 categories according to the objects of concern (rare disease drugs, rare disease medical insurance, rare disease medical and health services and rare disease patient groups). On the whole, the emotional tendency of the Internet public towards each topic showed a low positive and high negative tendency. CONCLUSIONS The public paid more attention to the price, research and development, supply and demand of rare disease drugs, and was deeply worried about the current medical status of rare diseases in China. To strengthen and improve the medical security for patients with rare diseases, such as actively carrying out public health services for rare diseases, strengthening cooperation in the diagnosis and treatment of rare diseases, and researching rare disease drugs, etc. Chinese medical and health departments can make concerted efforts in medical and health services, drug supply security, medical security and other social security.